Longevity & Aging
epigenetic information loss causes aging
In plain terms: Do cells age because they lose their instructions?
Part of: • Aging
Probably yes, but only shown in animals so far — in people the drift looks correlational, not proven cause.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Sinclair's Information Theory of Aging (ICE mouse, 2023 Cell). A single-lab CAUSAL theory; independent human work confirms methylation DRIFT with age but treats it as correlative/biomarker, not proven cause. Mouse-only.
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Nagar R, Schwartz Z, Katz A, Touitou N, Sharon E, Tzdaka K, Waner O, Shalev N, Clo R, Weiss L, Epstein B, Bernier M, Shtark RB, Banskota N, Lam KG, De S, Price NL, Lerrer B, Bar DZ, de Cabo R, Cohen HY 2026 · Nat Commun | animal | supports | moderate | SIRT6 overexpression reversed age-associated chromatin-accessibility changes and restored a more youthful epigenomic state in mice — new (2026) support that age-related epigenetic dysregulation is a manipulable driver, consistent with (but not proving in humans) the information-loss thesis. Animal. |
| Roux AE, Zhang C, Paw J, Zavala-Solorio J, Malahias E, Vijay T, Kolumam G, Kenyon C, Kimmel JC 2022 · Cell Systems | animal | mixed | moderate | Partial reprogramming restores youthful expression but transiently suppresses somatic identity; rejuvenation and de-differentiation partly separable |
| Lu JY, Tu WB, Li R, Weng M, Sanketi BD, Yuan B, Reddy P, Rodriguez Esteban C, Izpisua Belmonte JC 2025 · Cell | animal | mixed | moderate | Aging/disease 'mesenchymal drift' across 40 human tissues reversed by partial reprogramming; identity-loss correlative, reprogramming-causal in mice |
| Anton-Fernandez 2024 · Commun Biol | animal | supports | moderate | Cyclic neuron-restricted Yamanaka-factor expression reverses age epigenetic markers and improves memory in aged mice |
| Pérez RF, Tejedor JR, Fernández AF, Fraga MF 2026 · Nat Aging | observational | mixed | moderate | Argues epigenetic clocks are quantitative readouts of stochastic epigenetic DRIFT - treats methylation change as biomarker, not proven cause |
| Paine PT, Rechsteiner C, Morandini F, Desdín-Micó G, Mrabti C, Parras A, Haghani A, Brooke R, Horvath S, Seluanov A, Gorbunova V, Ocampo A 2023 · Front Aging | animal | mixed | low | Initiation-phase reprogramming reduces DNA damage in ERCC1 progeroid mice - independent support for reprogramming reversing aging hallmarks |
| Lu Y, Brommer B, Tian X, Krishnan A, Meer M, Wang C, Vera DL, Zeng Q, Yu D, Bonkowski MS, Yang JH, Zhou S, Hoffmann EM, Karg MM, Schultz MB, Kane AE, Davidsohn N, Korobkina E, Chwalek K, Rajman LA, Church GM, Hochedlinger K, Gladyshev VN, Horvath S, Levine ME, Gregory-Ksander MS, Ksander BR, He Z, Sinclair DA 2020 · Nature | animal | supports | moderate | OSK reprogramming restores youthful DNA methylation and reverses vision loss in mice - core evidence for reversible epigenetic-info-loss thesis |
| Haoui M, Reddy P, Izpisua Belmonte JC 2026 · Cell Stem Cell | mechanism | supports | low | Perspective, not evidence: 'This perspective highlights the therapeutic possibilities arising from the convergence of partial reprogramming with the innovative technology of ex vivo machine perfusion.' Asserts reprogramming can 'restore youthful epigenetic and transcriptional signatures without erasing cell identity' — does not test epigenetic loss as the cause of aging. Review — zero weight. |
| Chondronasiou D, Gill D, Mosteiro L, Urdinguio RG, Berenguer-Llergo A, Aguilera M, Durand S, Aprahamian F, Nirmalathasan N, Abad M, Martin-Herranz DE, Stephan-Otto Attolini C, Prats N, Kroemer G, Fraga MF, Reik W, Serrano M 2022 · Aging Cell | animal | supports | moderate | Single transient OSKM cycle reverses age-related DNA-methylation, transcriptomic and metabolomic changes in naturally aged mouse tissues |
| Fan X, Qian Q, Li W, Liu T, Zeng C, Jia P, Lin H, Gao X, Jin L, Xia M, Wang S, Liu F 2025 · Genome Res | observational | mixed | moderate | Human EWAS: methylation drift accumulates with age & correlates with aging markers, but is correlative - supports drift, not Sinclair's causal claim |
| Ahmad U, Kumar D, Faiyazuddin M 2026 · Curr Stem Cell Res Ther | mechanism | mixed | low | Narrative review (abstract basis): 'This study aims to synthesize findings from studies on iPSC-based age reversal, covering mechanisms, therapeutic potential, challenges, and translational hurdles.' Restates that partial reprogramming restores youthful markers while 'major safety concerns remain, including genomic instability, tumorigenesis, and incomplete control over identity retention.' Review — zero weight. |
| Vaidya H, Jelinek J, Issa JJ 2025 · Epigenomes | observational | supports | low | Review: age methylation drift is real and links aging-cancer, but framed as mediator/biomarker, not proven sole driver |
| Wagner W 2026 · Ageing Res Rev | mechanism | mixed | moderate | Conceptual review, not evidence: 'This review argues that aging should not be interpreted exclusively as the result of random molecular damage or the output of a specific genetic program'; notes 'the functional relevance of these epigenetic modifications remains unproven'. Review — zero weight. |
| Scalf SM, Wu Q, Guo S 2025 · Curr Opin Genet Dev | mechanism | mixed | moderate | Perspective review: 'We synthesize our view of the molecular underpinning of cell fate plasticity, from which we speculate how to harness it'; cites that partial reprogramming 'reverses many hallmarks of aging2, even though the underlying mechanism remains unclear.' No own data — review, zero weight. |
| Mitchell W, Goeminne LJE, Tyshkovskiy A, Zhang S, Chen JY, Paulo JA, Pierce KA, Choy AH, Clish CB, Gygi SP, Gladyshev VN 2024 · eLife | in-vitro | supports | moderate | Chemical partial reprogramming lowers transcriptomic/epigenetic age of mouse fibroblasts - rejuvenation achievable without genetic OSK |
| Yang JH, Hayano M, Griffin PT, Amorim JA, Bonkowski MS, Apostolides JK, Salfati EL, Blanchette M, Munding EM, Bhakta M, Chew YC, Guo W, Yang X, Maybury-Lewis S, Tian X, Ross JM, Coppotelli G, Meer MV, Rogers-Hammond R, Vera DL, Lu YR, Pippin JW, Creswell ML, Dou Z, Xu C, Mitchell SJ, Das A, O'Connell BL, Thakur S, Kane AE, Su Q, Mohri Y, Nishimura EK, Schaevitz L, Garg N, Balta AM, Rego MA, Gregory-Ksander M, Jakobs TC, Zhong L, Wakimoto H, El Andari J, Grimm D, Mostoslavsky R, Wagers AJ, Tsubota K, Bonasera SJ, Palmeira CM, Seidman JG, Seidman CE, Wolf NS, Kreiling JA, Sedivy JM, Murphy GF, Green RE, Garcia BA, Berger SL, Oberdoerffer P, Shankland SJ, Gladyshev VN, Ksander BR, Pfenning AR, Rajman LA, Sinclair DA 2023 · Cell | animal | supports | moderate | ICE mice: inducing/repairing DNA breaks erodes the epigenome, advances the methylation clock & aging, partly reversed by OSK - single-lab, mouse-only ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.